3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
26
Small Cell Lung Carcinoma
22
Neuroblastoma
12
Fallopian Tube Neoplasms
12
Uterine Cervical Neoplasms
8
Carcinoma, Ovarian Epithelial
8
Lung Neoplasms
7
Neoplasm Metastasis
5
Carcinoma, Non-Small-Cell Lung
4
Leukemia, Myeloid, Acute
3
Ganglioneuroblastoma
3
Brain Neoplasms
3
Sarcoma
2
Recurrence
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Gliosarcoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Small Cell
2
Carcinoma, Neuroendocrine
2
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Retinoblastoma
1
Retinal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
Topotecan
×
Clear all
No trials found.